Report date: Wednesday, August 5, 2026 (after market close) | Call: Thursday, August 6, 2026, 1:00 p.m. ET
OXY heads into this print against the backdrop of the most volatile oil market in years. After averaging $71.93/bbl WTI and $77.93/bbl Brent in Q1 2026, prices spiked sharply in Q2/Q3 as the U.S.-Iran conflict escalated — Brent broke above $90 in mid-July on fears over Strait of Hormuz tanker traffic, and jumped further (Brent +7.9% to $90.74, WTI +6.6% to $84.46) after President Trump threatened retaliation against Iran. Oxy's own pre-announced "Q2 2026 Earnings Considerations" (filed July 10) show the impact directly: average realized worldwide oil price of $96.78/bbl (104% of WTI, 100% of Brent) versus $69.91/bbl in Q1 — a roughly 38% sequential jump. Average WTI/Brent for the quarter were $92.79/$97.06.
Two offsets are worth flagging up front: - Hedges cap some upside. Oxy layered in costless collars in February (100,000 bbl/d, March–Dec 2026, $55 WTI floor / ~$76 WTI weighted-average ceiling) before the conflict escalated. With WTI averaging ~$93 in Q2, those collars worked against the company — crude oil collar settlements reduced operating cash flow before working capital by $156 million in the quarter, per the earnings considerations filing. - Negative domestic gas pricing. The same filing shows realized domestic natural gas at -$0.80/Mcf (worldwide gas -$(0.80) blended, NYMEX averaged $2.89) — a reminder that Permian/Waha basis blowouts remain a headwind even as oil strength dominates the headline story.
Consensus currently models adjusted EPS of ~$1.84 and revenue of ~$7.1 billion for the quarter — a sharp step-up from Q1's $1.06 adjusted EPS, consistent with the oil-price surge. Shares have been volatile all year: OXY ran from the low-$40s in January to a 2026 high near $66 in late March (on debt-paydown/dividend-hike momentum), sold off to the high-$40s by late June as the stock lagged the macro rally, then rebounded into the high-$50s as the Iran conflict drove oil prices higher, closing near $55 heading into the print. Sell-side sentiment is mixed-to-modestly-positive: consensus price targets cluster in the low-to-mid $60s versus the current share price, implying meaningful upside if execution and capital-return signals hold up.
Three structural changes dominate the "what's different" list for anyone who hasn't followed OXY closely since late 2025:
OxyChem is gone. Occidental completed the $9.7 billion cash sale of Occidental Chemical Corporation to Berkshire Hathaway on January 2, 2026, with OxyChem now reported as discontinued operations in all periods. The gain flowed through Q1 2026 results (a ~$3.1 billion after-tax gain), which is why reported Q1 diluted EPS was $3.13 versus adjusted continuing-ops EPS of just $1.06 — expect the market to keep focusing on adjusted continuing-operations metrics going forward, not headline GAAP EPS.
Aggressive deleveraging. Since Q3 2025, Oxy has cut principal debt from ~$20.8 billion to $13.3 billion (as of the Q1 call, reflecting $7.1 billion of paydown through May 5), beating its own $14.3 billion interim target. Management's near-term priority remains reducing principal debt to a $10 billion milestone, which would cut the go-forward interest run-rate to ~$845 million/year (~$550 million below 2025). Debt tender offers in February (upsized to $1.2 billion) and covenant amendments in early 2026 were part of this push. Watch for an updated debt figure and commentary on what comes after $10 billion is reached — options on the table include building cash ahead of the August 2029 preferred redemption, further debt paydown, or opportunistic buybacks.
Leadership transition. CEO Vicki Hollub retired effective June 1, 2026, handing the reins to Richard Jackson (previously COO), who was already leading strategic commentary on the Q1 call. This is effectively Jackson's first full quarter as CEO and his first earnings call in that seat — investors will be listening for continuity vs. any shifts in capital-allocation philosophy (Oxy has resisted a formulaic buyback program in favor of discretionary/opportunistic returns).
1. Production and segment guidance execution. Q1 production of 1,426 Mboe/d beat the high end of guidance, and full-year guidance was raised to a 1.44 MMBoe/d midpoint. Q2 guidance flagged specific headwinds: Middle East disruptions at Al Hosn (expected to normalize by quarter-end), PSC entitlement effects from higher prices (which mechanically reduce reported international barrels), and a deliberate EOR portfolio optimization (trading scattered noncore fields for higher working interest in core floods) that trims volumes but is free-cash-flow accretive. Watch whether Al Hosn actually normalized and whether Permian/Gulf of America offset the EOR/Middle East drag as planned.
2. Midstream & Marketing strength. Oxy raised full-year midstream guidance to a $1.1 billion pre-tax midpoint (up ~$800 million from prior guidance) on wide Waha-to-Gulf-Coast gas spreads and strong gas-marketing optimization. This segment has been a repeated source of upside surprises; confirm whether that strength persisted through Q2 and how sulfur-sales disruption from Middle East logistics played out (guidance assumed a hit here, with normalization expected in H2).
3. Capital spending pace. Full-year capex guidance remains $5.5–5.9 billion, with Q2 spending expected higher than Q1's $1.6 billion as activity is weighted to H1. Confirm the range holds given any service-cost inflation chatter (management said this wasn't pressuring the plan as of May).
4. Hedging book and cash-flow mechanics. Given the sharp WTI move above the ~$76 collar ceiling, investors should look for confirmation that Oxy has not added new hedges (as stated in May) and get color on how much further upside is being foregone if prices stay elevated through year-end (hedges run March–December 2026).
5. STRATOS direct air capture update. Phase 2 construction was completed and Phase 1 commissioning finished, but Oxy flagged a non-process-related mechanical issue discovered after commissioning and said it would provide a repair timeline/schedule update "next quarter" — i.e., on this call. Management said it doesn't expect this to affect the 2026 capital range, but any change to that stance, or a cost/timeline update, would be a notable LCV-segment datapoint.
6. Capital returns and the post-$10B roadmap. With oil prices well above plan and debt paydown ahead of schedule, this is the print where investors will push hardest on: dividend growth pace (the quarterly dividend was already raised >8% to $0.26/share in Q4 2025, having doubled over four years), the size/timing of any buyback activity, and how much of the windfall from higher oil prices gets banked toward the balance sheet versus returned to shareholders.
7. New CEO's framing. Listen for how Richard Jackson frames capital priorities in his first quarter fully in the chair — particularly his prior comments about "measured reinvestment" once the macro is "clear," lowering base decline toward 20% via EOR/waterflood investment, and the 2026 target of $1.2 billion+ of incremental free cash flow versus 2025 (before the benefit of higher prices) — a target that should now be significantly exceeded given the oil-price backdrop.
| Metric | Q1 2026 (actual) | Q2 2026 (pre-announced/consensus) |
|---|---|---|
| Avg. WTI | $71.93/bbl | $92.79/bbl |
| Avg. Brent | $77.93/bbl | $97.06/bbl |
| Worldwide realized oil price | $69.91/bbl | $96.78/bbl |
| Adjusted EPS (continuing ops) | $1.06 | ~$1.84 (consensus) |
| Revenue | ~$5.1B | ~$7.1B (consensus) |
| Principal debt | $13.3B (as of May 5) | Update expected |
| Production | 1,426 Mboe/d | Guidance midpoint 1.44 MMBoe/d (FY) |
| Avg. diluted shares | 1,006.9M | 1,012.2M |
This is a high-visibility print because Oxy is essentially operating a "beta" trade on the Iran conflict's oil-price impact layered on top of a genuine self-help deleveraging story. The setup favors a strong headline beat on adjusted EPS and cash flow given the ~38% sequential jump in realized oil prices, but the real swing factors for the stock reaction will be: (1) how much of that upside was clipped by the February hedges, (2) whether debt is tracking toward the $10 billion milestone on schedule, (3) any signal on capital-return escalation (buybacks/dividend) now that the balance sheet is materially de-risked, and (4) the tone new CEO Richard Jackson sets on reinvestment discipline versus opportunistic growth in a market this volatile.